Skip to main content
. 2020 May 7;135(6):1313–1326. doi: 10.1097/AOG.0000000000003869

Table 2.

Secondary and Other Efficacy Endpoints After 6 Months and 12 Months of Elagolix Treatment in Women Treated With Up to 12 months of Elagolix*

graphic file with name ong-135-1313-g004.jpg